Sheaff Brock Investment Advisors, LLC Pfizer Inc Transaction History

Sheaff Brock Investment Advisors, LLC

$1.13 Billion
Q3 2024

A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 74,454 shares of PFE stock, worth $1.96 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

74,454

Previous 74,367 0.12%

Holding current value

$1.96 Million

Previous $2.08 Million 3.56%

% of portfolio

0.19%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$27.7 - $31.39 $2,409 - $2,730	87 Added 0.12%	74,454 $2.15 Million
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $90,203 - $105,701	-3,571 Reduced 4.58%	74,367 $2.08 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $30,757 - $35,319	1,188 Added 1.55%	77,938 $2.16 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $100,260 - $130,227	-3,837 Reduced 4.76%	76,750 $2.21 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $44,605 - $52,138	1,390 Added 1.76%	80,587 $2.67 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $89,577 - $103,639	-2,480 Reduced 3.04%	79,197 $2.9 Million
Q1 2023 May 01, 2023	SELL	$39.39 - $51.28 $44,431 - $57,843	-1,128 Reduced 1.36%	81,677 $3.33 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $49,557 - $64,691	1,187 Added 1.45%	82,805 $4.24 Million
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $36,495 - $44,552	834 Added 1.03%	81,618 $3.57 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $23,730 - $28,136	-510 Reduced 0.63%	80,784 $4.24 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $28,456 - $35,261	-622 Reduced 0.76%	81,294 $4.21 Million
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $192,716 - $285,670	4,664 Added 6.04%	81,916 $4.84 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $551,227 - $708,098	-14,044 Reduced 15.38%	77,252 $3.32 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $4,237 - $4,800	-118 Reduced 0.13%	91,296 $3.58 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $107,703 - $121,468	-3,216 Reduced 3.4%	91,414 $3.31 Million
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $489,967 - $623,035	14,639 Added 18.3%	94,630 $3.48 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $228,600 - $268,200	7,200 Added 9.89%	79,991 $2.94 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $10,451 - $12,679	-347 Reduced 0.47%	72,791 $2.38 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $311,980 - $445,752	-11,542 Reduced 13.63%	73,138 $2.39 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $33,940 - $38,518	1,031 Added 1.23%	84,680 $3.32 Million
Q3 2019 Oct 28, 2019	SELL	$32.49 - $42.13 $24,140 - $31,302	-743 Reduced 0.88%	83,649 $3.01 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $72,443 - $81,337	-1,959 Reduced 2.27%	84,392 $3.66 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $331,500 - $364,208	8,840 Added 11.4%	86,351 $3.67 Million
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $6.33 Million - $7.22 Million	-164,512 Reduced 67.97%	77,511 $3.38 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $188,723 - $228,909	-5,475 Reduced 2.21%	242,023 $10.7 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $238,808 - $254,593	-7,241 Reduced 2.84%	247,498 $8.98 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $9,924 - $11,513	-311 Reduced 0.12%	254,739 $9.04 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $90,001 - $95,494	-2,706 Reduced 1.05%	255,050 $9.24 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $31,124 - $34,286	1,004 Added 0.39%	257,756 $9.2 Million
Q2 2017 Aug 09, 2017	BUY	N/A	256,752	256,752 $8.62 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.

Account

Sheaff Brock Investment Advisors, LLC Pfizer Inc Transaction History